Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial

Overview of attention for article published in npj Primary Care Respiratory Medicine, May 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 12 X users
facebook: 1 Facebook page

guideline: 1 clinical guideline source

Readers on

mendeley: 77 Mendeley

So far, Altmetric has seen 13 X posts from 12 X users, with an upper bound of 34,742 followers.

Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial. https://t.co/MJkmF1NqEw

RT @76whit: Really important findings. We need to communicate better instructions around blue inhaler use. @PCRSUK @ARNS_UK https://t.co/Gg…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 9 additional X posts.